The Battle Over 340B Drug Pricing
Stay ahead of industry shifts and the constantly evolving 340B Drug Pricing landscape.
To help understand 340B and key updates affecting hospitals and health systems, RxBenefits has partnered with the American Society for Healthcare Human Resources Administration (ASHHRA) on a podcast series.
Listen to Episode 1 today to learn about:
- The Foundations of 340B: A quick look at the history of the program and how it helps healthcare providers reduce drug costs
- Election Impacts: Proposed legislative changes, including redefining nonprofit hospital status and pharmaceutical industry pressures
- Advocacy That Matters: How grassroots efforts are protecting 340B
- Contract Pharmacy Restrictions: How recent cases like Genesis Health are challenging 340B’s goals
Featured Experts:
- Sarah Hearn: 340B ACE, MPH, Strategic Healthcare Market Adviser, RxBenefits
- Rhiannon Klein: National Director of Advocacy, Community Voices for 340B
- Peggy Tighe: Lawyer & Legislative Consultant, Principal at Powers Pyles Sutter & Verville PC
Listen to the ASHHRA podcast now and be prepared to drive impactful 340B strategies for your organization.
Discover more about 340B and access expert insights.
Check out how RxBenefits’ 340B tools can help covered entities maximize their savings.
